Keryx Biopharmaceuticals Inc. (KERX)

5.03
NASDAQ : Health Technology
Prev Close 5.03
Day Low/High 0.00 / 0.00
52 Wk Low/High 3.92 / 8.38
Avg Volume 1.02M
Exchange NASDAQ
Shares Outstanding 120.53M
Market Cap 625.53M
EPS -1.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

First Week of April 20th Options Trading For Keryx Biopharmaceuticals (KERX)

First Week of April 20th Options Trading For Keryx Biopharmaceuticals (KERX)

Investors in Keryx Biopharmaceuticals Inc. saw new options become available this week, for the April 20th expiration.

Commit To Buy Keryx Biopharmaceuticals At $3, Earn 17.9% Annualized Using Options

Commit To Buy Keryx Biopharmaceuticals At $3, Earn 17.9% Annualized Using Options

Investors eyeing a purchase of Keryx Biopharmaceuticals Inc. shares, but cautious about paying the going market price of $4.42/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Why 2018 Will Be Better for Biotech Deals Than 2017

Why 2018 Will Be Better for Biotech Deals Than 2017

Analysts see a year of robust deal action ahead due in part to clarity from a tax standpoint.

KERX January 2020 Options Begin Trading

KERX January 2020 Options Begin Trading

Investors in Keryx Biopharmaceuticals Inc. saw new options begin trading today, for the January 2020 expiration.

Interesting KERX Put And Call Options For June 2018

Interesting KERX Put And Call Options For June 2018

Investors in Keryx Biopharmaceuticals Inc. saw new options begin trading this week, for the June 2018 expiration.

Keryx Biopharmaceuticals Becomes Oversold (KERX)

Keryx Biopharmaceuticals Becomes Oversold (KERX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

KERX Crosses Above Average Analyst Target

KERX Crosses Above Average Analyst Target

In recent trading, shares of Keryx Biopharmaceuticals Inc. have crossed above the average analyst 12-month target price of $7.67, changing hands for $7.95/share.

First Week of KERX November 17th Options Trading

First Week of KERX November 17th Options Trading

Investors in Keryx Biopharmaceuticals Inc. saw new options become available this week, for the November 17th expiration.

Keryx Biopharmaceuticals Reaches Analyst Target Price

Keryx Biopharmaceuticals Reaches Analyst Target Price

In recent trading, shares of Keryx Biopharmaceuticals Inc. have crossed above the average analyst 12-month target price of $7.67, changing hands for $7.80/share.

First Week of October 20th Options Trading For Keryx Biopharmaceuticals (KERX)

First Week of October 20th Options Trading For Keryx Biopharmaceuticals (KERX)

Investors in Keryx Biopharmaceuticals Inc. saw new options become available this week, for the October 20th expiration.

10 Sectors That Will Profit Big-Time From Oil's Crash

10 Sectors That Will Profit Big-Time From Oil's Crash

Oil prices are tumbling down. Bad news for companies and petro states, but great news at the pump and for these ten industries...

TheStreet Quant Rating: D- (Sell)